Hemispherx BioPharma, Inc. Competitors

HEB 
$0.2
*  
0.0045
2.2%
Get HEB Alerts
*Delayed - data as of Jul. 1, 2015 13:55 ET  -  Find a broker to begin trading HEB now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    HEB Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Hemispherx BioPharma, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap ▼
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 115.67 -1.41 ▼ 5,967,263 $ 118.60
$ 115.55
$ 123.37
$ 83.32
13.13 169,989,326,020
Amgen Inc.
AMGN: NASDAQ-GS
$ 154.12 0.60 ▲ 1,229,435 $ 155.75
$ 153.43
$ 173.60
$ 114.93
20.8 117,181,134,880
Biogen Inc.
BIIB: NASDAQ-GS
$ 404.96 1.02 ▲ 526,632 $ 409.98
$ 404.64
$ 480.18
$ 290.85
29.22 95,258,740,800
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 47.39 -1.01 ▼ 449,509 $ 48.915
$ 46.985
$ 49.84
$ 30.05
NE 5,918,394,930
Qiagen N.V.
QGEN: NASDAQ-GS
$ 25.07 0.28 ▲ 642,140 $ 25.24
$ 25.03
$ 25.91
$ 20.73
53.34 5,834,716,590
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 163.62 -4.75 ▼ 494,473 $ 170.69
$ 163.02
$ 197.35
$ 29.73
NE 5,371,480,980
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 51.75 -1.58 ▼ 2,768,690 $ 55.26
$ 51.33
$ 69.28
$ 34.71
NE 4,679,545,500
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 47.57 -0.19 ▼ 293,499 $ 48.89
$ 47.16
$ 49.49
$ 12.6325
NE 4,063,334,260
Bio-Techne Corp
TECH: NASDAQ-GS
$ 97.18 -1.29 ▼ 91,514 $ 99.11
$ 97.18
$ 103.56
$ 86.01
33.51 3,610,528,540
Novavax, Inc.
NVAX: NASDAQ-GS
$ 11 -0.14 ▼ 2,132,258 $ 11.29
$ 10.89
$ 11.45
$ 3.92
NE 2,948,330,000
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 22.43 -0.15 ▼ 997,491 $ 23.1585
$ 22.30
$ 22.845
$ 7.51
NE 2,854,441,800
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 113.67 -1.49 ▼ 43,046 $ 116.76
$ 113.0801
$ 121.22
$ 43.2101
39.2 2,825,608,860
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 61.08 0.11 ▲ 1,485,756 $ 63.91
$ 60.40
$ 89.21
$ 21
NE 2,630,043,720
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 8.08 -0.19 ▼ 1,865,758 $ 8.40
$ 8.05
$ 9.89
$ 4.90
NE 1,523,580,960
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 22.35 -0.46 ▼ 397,182 $ 23.16
$ 22.10
$ 25.56
$ 9.38
NE 1,522,772,550
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 59.50 -0.77 ▼ 80,218 $ 61.99
$ 59.02
$ 79.50
$ 40.16
NE 1,460,368,000
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.22 -1.11 ▼ 366,440 $ 33.83
$ 32.20
$ 45.45
$ 28.26
97.64 1,378,726,020
Repligen Corporation
RGEN: NASDAQ-GS
$ 40.90 -0.37 ▼ 99,438 $ 41.85
$ 40.80
$ 42.48
$ 18.23
194.76 1,343,646,800
Adaptimmune Therapeutics plc
ADAP: NASDAQ-GS
$ 17.34 -0.99 ▼ 438,306 $ 18.8399
$ 17.34
$ 21.57
$ 13.75
NE 1,194,899,400
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 30.59 0.81 ▲ 228,265 $ 32.49
$ 30.35
$ 30.04
$ 20.2601
NE 1,185,209,550
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 47.07 -5.69 ▼ 325,075 $ 53.872
$ 47.07
$ 64.35
$ 9.66
NE 1,146,625,200
Cellectis S.A.
CLLS: NASDAQ-GM
$ 34.71 -1.37 ▼ 129,476 $ 36.75
$ 34.4812
$ 50
$ 30.40
NE 1,144,353,990
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 29.51 0.61 ▲ 136,095 $ 29.74
$ 28.69
$ 33.30
$ 12.27
NE 1,116,687,910
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS
$ 14.52 -0.41 ▼ 556,845 $ 15.17
$ 14.52
$ 16.43
$ 7.85
NE 1,053,004,920
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 6.34 -0.09 ▼ 1,670,514 $ 6.52
$ 6.30
$ 10.26
$ 6.18
3.25 1,040,343,280